The expression and distribution of SV2A during different stages of epilepsy are important for revealing the antiepileptic mechanism of LEV and the patterns of the occurrence and development of epilepsy, providing significant guidance for the clinical treatment and prevention of epilepsy. Here, SV2A is linked to epilepsy.